Authors

• Luke Ardolino (ORCID: https://orcid.org/0000-0002-8998-7141)
• Diana Gutiérrez
• Peter J. Meikle (ORCID: https://orcid.org/0000-0002-2593-4665)
• Rhiannon Mellor (ORCID: https://orcid.org/0000-0003-3251-3874)
• Blossom Mak (ORCID: https://orcid.org/0000-0003-3068-2498)
• Nicole Yeung (ORCID: https://orcid.org/0000-0002-9855-5789)
• Martina Raneri
• Kevin Huynh (ORCID: https://orcid.org/0000-0001-6170-2207)
• Tania Moujaber (ORCID: https://orcid.org/0000-0002-0688-3364)
• Lisa M. Butler (ORCID: https://orcid.org/0000-0003-2698-3220)
• David J. Handelsman (ORCID: https://orcid.org/0000-0002-4200-7476)
• Hui‐Ming Lin (ORCID: https://orcid.org/0000-0003-4892-6008)
• Andrew J. Hoy (ORCID: https://orcid.org/0000-0003-3922-1137)
• Neil Portman (ORCID: https://orcid.org/0000-0003-0248-0258)
• Ran Kim (ORCID: https://orcid.org/0000-0002-0241-2071)
• Tahlia Scheinberg (ORCID: https://orcid.org/0000-0003-4539-6216)
• Lisa Glen Horvath (ORCID: https://orcid.org/0000-0001-6842-9223)
• Anthony M. Joshua (ORCID: https://orcid.org/0000-0001-5159-4580)

Institutions

• The University of Sydney (AU)
• Garvan Institute of Medical Research (AU)
• Baker Heart and Diabetes Institute (AU)
• La Trobe University (AU)
• Westmead Hospital (AU)
• UNSW Sydney (AU)
• St Vincent's Hospital Sydney (AU)
• Chris O’Brien Lifehouse (AU)
• St Vincent's Clinic (AU)
• South Australian Health and Medical Research Institute (AU)
• Anzac Research Institute (AU)

Publication Details

Journal

EBioMedicine

Published

2025-12-08

DOI

https://doi.org/10.1016/j.ebiom.2025.106058

Citations

2

Primary Topic

Sphingolipid Metabolism and Signaling

Type

article

Field-Weighted Citation Impact

1.61